Accompanying GLP-1 therapy: from the first injection to tapering off
Updated: 2026-07
GLP-1 therapies (Wegovy, Ozempic, Mounjaro, Saxenda) run in phases with different needs: titration, everyday use, tapering. A phase-aware companion adapts support and information to the current phase — neutral and ad-free.
A GLP-1 therapy is not a single moment but a course: cautious initial dosing, weeks of getting used to it, the long everyday phase, and eventually tapering off. Each phase raises different questions.
Generic apps treat everyone the same. More helpful is a companion that knows which phase you are in — and that stays neutral, without advertising pressure.
How it works
- 01
Determine the phase
Onset, everyday use, or tapering — the companion adapts accordingly.
- 02
Account for the drug
Whether injectable or oral, Wegovy or Mounjaro — the course differs.
- 03
Track everyday use
Document progress and wellbeing over time.
- 04
Connect
A public community forum complements the individual companion.
Why it fits here
Penday is built phase-aware — from the first injection through everyday use to tapering, for Wegovy, Ozempic, Mounjaro, and Saxenda.
Neutral, ad-free, and EU-hosted; a public community forum complements the individual companion.
FAQ
Does Penday replace medical advice?
No. Penday accompanies the therapy informatively; medical decisions belong in a doctor’s hands.
Does it support different drugs?
Yes, Penday accounts for injectable and oral GLP-1 therapies such as Wegovy, Ozempic, Mounjaro, and Saxenda.
Is Penday ad-funded?
No, Penday is designed to be neutral, ad-free, and EU-hosted.
Penday
Penday is built phase-aware — from the first injection through everyday use to tapering, for Wegovy, Ozempic, Mounjaro, and Saxenda.
Neutral, ad-free, and EU-hosted; a public community forum complements the individual companion.